ArticleFrontiers in public health2024
Detecting anomalies in smart wearables for hypertension: a deep learning mechanism.
Article in Frontiers in public health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- The role of artificial intelligence in hypertension management.Current opinion in nephrology and hypertension · 2026Review
- Federated Learning in Public Health: A Systematic Review of Decentralized, Equitable, and Secure Disease Prevention Approaches.Healthcare (Basel, Switzerland) · 2025Review
- A study on the relationship between technological affordance of age-appropriate smart wearable devices and the well-being of older adults.Frontiers in public health · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: The growing demand for real-time, affordable, and accessible healthcare has underscored the need for advanced technologies that can provide timely health monitoring. One such area is predicting arterial blood pressure (BP) using non-invasive methods, which is crucial for managing cardiovascular diseases. This research aims to address the limitations of current healthcare systems, particularly in remote areas, by leveraging deep learning techniques in Smart Health Monitoring (SHM). Methods: This paper introduces a novel neural network architecture, ResNet-LSTM, to predict BP from physiological signals such as electrocardiogram (ECG) and photoplethysmogram (PPG). The combination of ResNet's feature extraction capabilities and LSTM's sequential data processing offers improved prediction accuracy. Comprehensive error analysis was conducted, and the model was validated using Leave-One-Out (LOO) cross-validation and an additional dataset. Results: The ResNet-LSTM model showed superior performance, particularly with PPG data, achieving a mean absolute error (MAE) of 6.2 mmHg and a root mean square error (RMSE) of 8.9 mmHg for BP prediction. Despite the higher computational cost (~4,375 FLOPs), the improved accuracy and generalization across datasets demonstrate the model's robustness and suitability for continuous BP monitoring. Discussion: The results confirm the potential of integrating ResNet-LSTM into SHM for accurate and non-invasive BP prediction. This approach also highlights the need for accurate anomaly detection in continuous monitoring systems, especially for wearable devices. Future work will focus on enhancing cloud-based infrastructures for real-time analysis and refining anomaly detection models to improve patient outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.